79 related articles for article (PubMed ID: 22846800)
1. DDB2 is a novel AR interacting protein and mediates AR ubiquitination/degradation.
Chang SW; Su CH; Chen HH; Huang CW; Tsao LP; Tsao YP; Chen SL
Int J Biochem Cell Biol; 2012 Nov; 44(11):1952-61. PubMed ID: 22846800
[TBL] [Abstract][Full Text] [Related]
2. NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.
Chen HH; Fan P; Chang SW; Tsao YP; Huang HP; Chen SL
Oncotarget; 2017 Mar; 8(13):21501-21515. PubMed ID: 28212551
[TBL] [Abstract][Full Text] [Related]
3. The cullin 4B-based UV-damaged DNA-binding protein ligase binds to UV-damaged chromatin and ubiquitinates histone H2A.
Guerrero-Santoro J; Kapetanaki MG; Hsieh CL; Gorbachinsky I; Levine AS; Rapić-Otrin V
Cancer Res; 2008 Jul; 68(13):5014-22. PubMed ID: 18593899
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
5. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation by melatonin of cell growth and androgen receptor binding to the androgen response element in prostate cancer cells.
Rimler A; Lupowitz Z; Zisapel N
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():45-9. PubMed ID: 12019351
[TBL] [Abstract][Full Text] [Related]
8. BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability.
Kuo PC; Huang CW; Lee CI; Chang HW; Hsieh SW; Chung YP; Lee MS; Huang CS; Tsao LP; Tsao YP; Chen SL
Br J Cancer; 2015 Jan; 112(2):391-402. PubMed ID: 25461807
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
10. Damage-specific DNA binding protein 1 (DDB1): a protein with a wide range of functions.
Iovine B; Iannella ML; Bevilacqua MA
Int J Biochem Cell Biol; 2011 Dec; 43(12):1664-7. PubMed ID: 21959250
[TBL] [Abstract][Full Text] [Related]
11. Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer.
Reddy GP; Barrack ER; Dou QP; Menon M; Pelley R; Sarkar FH; Sheng S
J Cell Biochem; 2006 Aug; 98(6):1408-23. PubMed ID: 16619263
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
13. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
14. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
Xie Y; Wolff DW; Lin MF; Tu Y
Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
[TBL] [Abstract][Full Text] [Related]
16. Cellular concentrations of DDB2 regulate dynamic binding of DDB1 at UV-induced DNA damage.
Alekseev S; Luijsterburg MS; Pines A; Geverts B; Mari PO; Giglia-Mari G; Lans H; Houtsmuller AB; Mullenders LH; Hoeijmakers JH; Vermeulen W
Mol Cell Biol; 2008 Dec; 28(24):7402-13. PubMed ID: 18936169
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
[TBL] [Abstract][Full Text] [Related]
18. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
[TBL] [Abstract][Full Text] [Related]
19. The androgen receptor and prostate cancer invasion.
Bonaccorsi L; Muratori M; Marchiani S; Forti G; Baldi E
Mol Cell Endocrinol; 2006 Feb; 246(1-2):157-62. PubMed ID: 16376012
[TBL] [Abstract][Full Text] [Related]
20. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
